Target intelligence / Profile preview

Endoplasmic reticulum α-1,2-mannosidase I (ERManI)

Target
ERManI
Molecular classification
Enzyme, Glycoside Hydrolase, GH47
01

Overview

Endoplasmic reticulum α-1,2-mannosidase I (ERManI) is a type II transmembrane glycoside hydrolase enzyme that plays a critical role in the maturation and quality control of N-linked glycoproteins within the secretory pathway of eukaryotic cells. It is primarily responsible for trimming a single α-1,2-linked mannose residue from high-mannose oligosaccharides on nascent glycoproteins. This enzyme acts as a key regulator in protein quality control by generating degradation signals on misfolded glycoproteins, marking them for recognition and subsequent degradation via the ER-associated degradation (ERAD) pathway. While originally thought to reside exclusively in the ER, recent studies suggest a predominant localization in the Golgi complex, contributing to both protein folding quality control and retrograde transport mechanisms. Deficiency or dysfunction can disrupt normal protein homeostasis leading to accumulation of misfolded glycoproteins, potentially implicating it in certain congenital disorders of glycosylation (CDG).

Other names
ER mannosidase IMannosidase alpha class 1B member 1MAN1B1
02

Mechanism of action

Inhibition of α-1,2-mannose trimming from N-glycans

03

Biological functions

N-glycan processingProtein quality controlER-associated degradation (ERAD) pathwayGlycoprotein folding
04

Disease associations

Congenital disorders of glycosylation (CDG)
05

Safety considerations

Disruption of protein homeostasisPotential for off-target effects on other glycosidases

Beyond the preview

Go deeper on Endoplasmic reticulum α-1,2-mannosidase I (ERManI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoplasmic reticulum α-1,2-mannosidase I (ERManI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call